As “Uptober” Ignites Crypto Market, Bonk, Inc. Revs Up Its Revenue-Generating Engine

(NASDAQ:BNKK),(NASDAQ:BNKKW), Company to Capitalize on its Position as the Most Widely Held Token on Solana and a Historically Strong Q4 for Digital Assets SCOTTSDALE, AZ, Oct. 14, 2025 (GLOBE NEWSWIRE) — Bonk, Inc. (Nasdaq: BNKK) (the “Company”), following its recent corporate rebranding, today is providing shareholders with a deeper insight into the unique and powerful […]

TTM Technologies, Inc. to Conduct Third Quarter 2025 Conference Call on October 29, 2025

(NASDAQ:TTMI), SANTA ANA, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) — October 14, 2025 – TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, October 29, 2025, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its third quarter 2025 performance. Access to the conference call will be available by clicking on the

Bombardier Defense and SNC Announce 10-year Service Agreement in Support of U.S. Military Program

(TSX:BBD-A),(TSX:BBD-B),(OTC US:BDRBF),(Other OTC:BDRBF), Agreement covers two Bombardier Global 6500 aircraft – equipped with SNC's RAPCON-X(R) technology – that SNC owns and operates for a U.S. military customer SNC will benefit from the Bombardier Smart Services Defense program, which allows for predictable and transparent operating costs WASHINGTON, Oct. 14, 2025 (GLOBE NEWSWIRE) — Bombardier Defense and

Critical Minerals Becoming More Critical as U.S. Government’s Proposed Funding Expected to Accelerate Growth

(Frankfurt:QN90),(NYSE:MP),(NYSE:UAMY),(Other OTC:MILIF),(NASDAQ:PPTA),(TSX:PPTA),(NasdaqGM:CRML),(CNSX:MILI.CN), PALM BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) — MarketNewsUpdates News Commentary The U.S. Government has recently been showing that Critical Minerals just became much more critical for the country in the near and long future. The present administration has made it clear: securing domestic supply chains for critical minerals is non-negotiable. Through

Profound Medical to Participate in the Stifel 2025 Healthcare Conference

(TSX:PRN),(NASDAQ:PROF), TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company's business at the Stifel 2025 Healthcare Conference on

Microbot Medical(R) Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY(R) Endovascular Robotic System

(NASDAQ:MBOT), The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY(R) during Q4 This Year HINGHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributer of the innovative LIBERTY(R) Endovascular Robotic System,

Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research

(NASDAQ:CLRB),(NASDAQ:CLRBW),(NASDAQ:CLRBZ), FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod Longcor, chief operating officer of Cellectar, presented positive preclinical data in a poster at the American Association for

Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners

(NASDAQ:CLOV), SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) — Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered value-based care enablement company, today announced that its technology platform has once again powered top-tier HEDIS results for Clover Health Medicare Advantage plans through

Iterum Therapeutics to Present Data at IDWeek 2025

(NASDAQ:ITRM), DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that two posters will be presented at the Infectious Disease Society

Schwazze Reaches Agreement to Restructure its Balance Sheet and Portfolio of Assets

(Other OTC:SHWZ),(OTC US:SHWZ),(Neo:SHWZ),(Neo:SHWZ.NE), DENVER, Oct. 14, 2025 (GLOBE NEWSWIRE) — Medicine Man Technologies, Inc., operating as Schwazze (OTC: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), announced it has entered into a Restructuring Support Agreement (“RSA”) with an affiliate of Vireo Growth Inc. (“Vireo”), which holds a majority of the Company's outstanding 13% senior secured

Scroll to Top